2802 Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study

2015 ◽  
Vol 51 ◽  
pp. S558 ◽  
Author(s):  
E. Del Barco Morillo ◽  
R. Mesia ◽  
J.C. Adansa Klain ◽  
S. Vazquez Fernández ◽  
J. Martínez Galan ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
First Line ◽  
Recurrent Head

Hyperfractionated reirradiation with cetuximab for recurrent head and neck cancer: The GORTEC 2008-01 multicentric phase II study.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 6034-6034 ◽  
Author(s):  
Mathilde Saint-Ghislain ◽  
Yungan Tao ◽  
Marc Alfonsi ◽  
Pierre Boisselier ◽  
Muriel Garcia-Ramirez ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Recurrent Head

Combination chemotherapy with carboplatin and bleomycin for advanced and recurrent head and neck cancer: A phase II study

1988 ◽  
Vol 39 (3) ◽  
pp. 215-216 ◽  
Author(s):  
Jose L. Gonzalez-Vela ◽  
Lawrence Panasci ◽  
Martin Black ◽  
Michael Pollak ◽  
Richard Margolese
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Combination Chemotherapy ◽  
Phase Ii Study ◽  
Recurrent Head

Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

Oral Oncology ◽  
2016 ◽  
Vol 62 ◽  
pp. 54-59 ◽  
Author(s):  
Elvira del Barco Morillo ◽  
Ricard Mesía ◽  
Juan Carlos Adansa Klain ◽  
Silvia Vázquez Fernández ◽  
Joaquina Martínez-Galán ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

A Phase II Study of Topotecan in Patients with Recurrent Head and Neck Cancer

1997 ◽  
Vol 20 (3) ◽  
pp. 298-302 ◽  
Author(s):  
Francisco Robert ◽  
Seng-jaw Soong ◽  
Richard H. Wheeler
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Recurrent Head

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

2013 ◽  
Vol 109 (2) ◽  
pp. 281-285 ◽  
Author(s):  
Eric F. Lartigau ◽  
Emmanuelle Tresch ◽  
Juliette Thariat ◽  
Pierre Graff ◽  
Bernard Coche-Dequeant ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Recurrent Head
Sign in / Sign up

Export Citation Format

Share Document